{"count": 5, "results": [{"_id": "33490865", "pmid": 33490865, "title": "Pilot Study Assessing Tolerability and Metabolic Effects of Metformin in Patients With Li-Fraumeni Syndrome.", "journal": "JNCI Cancer Spectr", "authors": ["Walcott FL", "Wang PY", "Bryla CM", "Huffstutler RD", "Singh N", "Pollak MN", "Khincha PP", "Savage SA", "Mai PL", "Dodd KW", "Hwang PM", "Fojo AT", "Annunziata CM"], "date": "2020-07-18T00:00:00Z", "doi": "10.1093/jncics/pkaa063", "meta_date_publication": "2020 Dec", "meta_volume": "4", "meta_issue": "6", "meta_pages": "pkaa063", "score": 50275.203, "text_hl": "Pilot Study Assessing Tolerability and Metabolic Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_Li_Fraumeni_Syndrome</m> @DISEASE_MESH:D016864 @@@Li-Fraumeni Syndrome@@@.", "citations": {"NLM": "Walcott FL, Wang PY, Bryla CM, Huffstutler RD, Singh N, Pollak MN, Khincha PP, Savage SA, Mai PL, Dodd KW, Hwang PM, Fojo AT, Annunziata CM. Pilot Study Assessing Tolerability and Metabolic Effects of Metformin in Patients With Li-Fraumeni Syndrome. JNCI Cancer Spectr. 2020 Dec;4(6):pkaa063. PMID: 33490865", "BibTeX": "@article{33490865, title={Pilot Study Assessing Tolerability and Metabolic Effects of Metformin in Patients With Li-Fraumeni Syndrome.}, author={Walcott FL and Wang PY and Bryla CM and Huffstutler RD and Singh N and Pollak MN and Khincha PP and Savage SA and Mai PL and Dodd KW and Hwang PM and Fojo AT and Annunziata CM}, journal={JNCI Cancer Spectr}, volume={4}, number={6}, pages={pkaa063}}"}}, {"_id": "38308321", "pmid": 38308321, "pmcid": "PMC10837926", "title": "Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol", "journal": "Trials", "authors": ["Dixon-Zegeye M", "Shaw R", "Collins L", "Perez-Smith K", "Ooms A", "Qiao M", "Pantziarka P", "Izatt L", "Tischkowitz M", "Harrison RE", "George A", "Woodward ER", "Lord S", "Hawkes L", "Evans DG", "Franklin J", "Hanson H", "Blagden SP"], "date": "2024-02-03T00:00:00Z", "doi": "10.1186/s13063-024-07929-w", "meta_date_publication": "2024 Feb 3", "meta_volume": "25", "meta_issue": "1", "meta_pages": "103", "score": 50267.574, "text_hl": "Pilot trial: short-term administration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to adults with @<m>DISEASE_Li_Fraumeni_Syndrome</m> @DISEASE_MESH:D016864 @@@LFS@@@", "citations": {"NLM": "Dixon-Zegeye M, Shaw R, Collins L, Perez-Smith K, Ooms A, Qiao M, Pantziarka P, Izatt L, Tischkowitz M, Harrison RE, George A, Woodward ER, Lord S, Hawkes L, Evans DG, Franklin J, Hanson H, Blagden SP. Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol Trials. 2024 Feb 3;25(1):103. PMID: 38308321", "BibTeX": "@article{38308321, title={Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol}, author={Dixon-Zegeye M and Shaw R and Collins L and Perez-Smith K and Ooms A and Qiao M and Pantziarka P and Izatt L and Tischkowitz M and Harrison RE and George A and Woodward ER and Lord S and Hawkes L and Evans DG and Franklin J and Hanson H and Blagden SP}, journal={Trials}, volume={25}, number={1}, pages={103}}"}}, {"_id": "27869650", "pmid": 27869650, "title": "Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome.", "journal": "J Clin Invest", "authors": ["Wang PY", "Li J", "Walcott FL", "Kang JG", "Starost MF", "Talagala SL", "Zhuang J", "Park JH", "Huffstutler RD", "Bryla CM", "Mai PL", "Pollak M", "Annunziata CM", "Savage SA", "Fojo AT", "Hwang PM"], "date": "2017-01-03T00:00:00Z", "doi": "10.1172/JCI88668", "meta_date_publication": "2017 Jan 3", "meta_volume": "127", "meta_issue": "1", "meta_pages": "132-136", "score": 50063.098, "text_hl": "In a pilot study, @<m>DISEASE_Li_Fraumeni_Syndrome</m> @DISEASE_MESH:D016864 @@@LFS@@@ @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ exhibited decreases in mitochondrial activity concomitant with activation of antiproliferation signaling, thus reproducing the effects of disrupting mitochondrial function observed in @<m>DISEASE_Li_Fraumeni_Syndrome</m> @DISEASE_MESH:D016864 @@@LFS@@@ @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Wang PY, Li J, Walcott FL, Kang JG, Starost MF, Talagala SL, Zhuang J, Park JH, Huffstutler RD, Bryla CM, Mai PL, Pollak M, Annunziata CM, Savage SA, Fojo AT, Hwang PM. Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome. J Clin Invest. 2017 Jan 3;127(1):132-136. PMID: 27869650", "BibTeX": "@article{27869650, title={Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome.}, author={Wang PY and Li J and Walcott FL and Kang JG and Starost MF and Talagala SL and Zhuang J and Park JH and Huffstutler RD and Bryla CM and Mai PL and Pollak M and Annunziata CM and Savage SA and Fojo AT and Hwang PM}, journal={J Clin Invest}, volume={127}, number={1}, pages={132-136}}"}}, {"_id": "28537659", "pmid": 28537659, "title": "Metformin improves the glucose and lipid metabolism via influencing the level of serum total bile acids in rats with streptozotocin-induced type 2 diabetes mellitus.", "journal": "Eur Rev Med Pharmacol Sci", "authors": ["Meng XM", "Ma XX", "Tian YL", "Jiang Q", "Wang LL", "Shi R", "Ding L", "Pang SG"], "date": "2017-05-01T00:00:00Z", "meta_date_publication": "2017 May", "meta_volume": "21", "meta_issue": "9", "meta_pages": "2232-2237", "score": 50054.793, "text_hl": "After administration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, the levels of FBG, @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@TG@@@, TC, LDLC and TBA in @DISEASE_Myotonic_Dystrophy @DISEASE_MESH:D009223 @@@DM@@@ and @<m>DISEASE_Li_Fraumeni_Syndrome</m> @DISEASE_MESH:D016864 @@@LI@@@ group were higher than NC group. ", "citations": {"NLM": "Meng XM, Ma XX, Tian YL, Jiang Q, Wang LL, Shi R, Ding L, Pang SG. Metformin improves the glucose and lipid metabolism via influencing the level of serum total bile acids in rats with streptozotocin-induced type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci. 2017 May;21(9):2232-2237. PMID: 28537659", "BibTeX": "@article{28537659, title={Metformin improves the glucose and lipid metabolism via influencing the level of serum total bile acids in rats with streptozotocin-induced type 2 diabetes mellitus.}, author={Meng XM and Ma XX and Tian YL and Jiang Q and Wang LL and Shi R and Ding L and Pang SG}, journal={Eur Rev Med Pharmacol Sci}, volume={21}, number={9}, pages={2232-2237}}"}}, {"_id": "28373404", "pmid": 28373404, "title": "Precancer Atlas to Drive Precision Prevention Trials.", "journal": "Cancer Res", "authors": ["Spira A", "Yurgelun MB", "Alexandrov L", "Rao A", "Bejar R", "Polyak K", "Giannakis M", "Shilatifard A", "Finn OJ", "Dhodapkar M", "Kay NE", "Braggio E", "Vilar E", "Mazzilli SA", "Rebbeck TR", "Garber JE", "Velculescu VE", "Disis ML", "Wallace DC", "Lippman SM"], "date": "2017-04-01T00:00:00Z", "doi": "10.1158/0008-5472.CAN-16-2346", "meta_date_publication": "2017 Apr 1", "meta_volume": "77", "meta_issue": "7", "meta_pages": "1510-1541", "score": 50027.344, "text_hl": "Emerging genetic and pharmacologic (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@) disruption of mitochondrial (mt) respiration increased autophagy to prevent @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ in a @<m>DISEASE_Li_Fraumeni_Syndrome</m> @DISEASE_MESH:D016864 @@@Li-Fraumeni@@@ @SPECIES_10090 @@@mouse@@@ model (biology reproduced in clinical pilot) and revealed profound influences of subtle changes in mt DNA background variation on @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@, aging, and @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ risk. ", "citations": {"NLM": "Spira A, Yurgelun MB, Alexandrov L, Rao A, Bejar R, Polyak K, Giannakis M, Shilatifard A, Finn OJ, Dhodapkar M, Kay NE, Braggio E, Vilar E, Mazzilli SA, Rebbeck TR, Garber JE, Velculescu VE, Disis ML, Wallace DC, Lippman SM. Precancer Atlas to Drive Precision Prevention Trials. Cancer Res. 2017 Apr 1;77(7):1510-1541. PMID: 28373404", "BibTeX": "@article{28373404, title={Precancer Atlas to Drive Precision Prevention Trials.}, author={Spira A and Yurgelun MB and Alexandrov L and Rao A and Bejar R and Polyak K and Giannakis M and Shilatifard A and Finn OJ and Dhodapkar M and Kay NE and Braggio E and Vilar E and Mazzilli SA and Rebbeck TR and Garber JE and Velculescu VE and Disis ML and Wallace DC and Lippman SM}, journal={Cancer Res}, volume={77}, number={7}, pages={1510-1541}}"}}]}